Sepsis and Myocarditis
Cardiac Manifestations of Sepsis and Its Association With Disease Outcome: A Prospective Cohort Study
About This Trial
This prospective cohort study aims to investigate the cardiac manifestations of sepsis and their influence on disease outcomes among adult patients at Jimma University Medical Center, Ethiopia, from May 2025 to May 2026. The research will include adults aged 18 and older with sepsis, categorizing them based on the presence or absence of cardiac involvement, which will be assessed through clinical symptoms, biomarkers, ECG, and echocardiographic findings. The study will evaluate the persistence of cardiac abnormalities, functional capacity, and survival over one year, utilizing structured data collection and advanced statistical methods, including survival analysis and regression techniques, to identify predictors of adverse outcomes.
Who May Be Eligible (Plain English)
Original Eligibility Criteria
View original clinical language
Treatments Being Tested
Standard treatment for sepsis of any focus
This group of patients will be treated for the sepsis of any focus as per standard.
Treatment for the sepsis with standard management of cardiac failure
This group of patients will be treated for the sepsis and management of cardiac failure with additional supportive care cocktails based on the specific indication.